Next Article in Journal
Association between Socioecological Status, Nutrient Intake, and Cancer Screening Behaviors in Adults Aged 40 and Over: Insights from the Eighth Korea National Health and Nutrition Examination Survey (KNHANES, 2019)
Next Article in Special Issue
Research on Application of Japanese Quince (Chaenomeles L.) and Pork Collagen in Dark Chocolate—Benefits in Prevention of Inflammation In Vitro Model
Previous Article in Journal
Intervention Strategies to Address Barriers and Facilitators to a Healthy Lifestyle Using the Behaviour Change Wheel: A Qualitative Analysis of the Perspectives of Postpartum Women
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation

by
Jabir Khan
1,†,
Palwasha Gul
1,†,
Muhammad Tayyab Rashid
1,
Qingyun Li
1 and
Kunlun Liu
1,2,*
1
College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China
2
School of Food and Strategic Reserves, Henan University of Technology, Zhengzhou 450001, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2024, 16(7), 1047; https://doi.org/10.3390/nu16071047
Submission received: 23 February 2024 / Revised: 28 March 2024 / Accepted: 28 March 2024 / Published: 3 April 2024
(This article belongs to the Special Issue Plant-Based Diets in the Prevention of Inflammation)

Abstract

:
Inflammation is an important biological response to any tissue injury. The immune system responds to any stimulus, such as irritation, damage, or infection, by releasing pro-inflammatory cytokines. The overproduction of pro-inflammatory cytokines can lead to several diseases, e.g., cardiovascular diseases, joint disorders, cancer, and allergies. Emerging science suggests that whole grains may lower the markers of inflammation. Whole grains are a significant source of dietary fiber and phenolic acids, which have an inverse association with the risk of inflammation. Both cereals and pseudo-cereals are rich in dietary fiber, e.g., arabinoxylan and β-glucan, and phenolic acids, e.g., hydroxycinnamic acids and hydroxybenzoic acids, which are predominantly present in the bran layer. However, the biological mechanisms underlying the widely reported association between whole grain consumption and a lower risk of disease are not fully understood. The modulatory effects of whole grains on inflammation are likely to be influenced by several mechanisms including the effect of dietary fiber and phenolic acids. While some of these effects are direct, others involve the gut microbiota, which transforms important bioactive substances into more beneficial metabolites that modulate the inflammatory signaling pathways. Therefore, the purpose of this review is twofold: first, it discusses whole grain dietary fiber and phenolic acids and highlights their potential; second, it examines the health benefits of these components and their impacts on subclinical inflammation markers, including the role of the gut microbiota. Overall, while there is promising evidence for the anti-inflammatory properties of whole grains, further research is needed to understand their effects fully.

1. Introduction

According to the American Association of Cereal Chemists International (AACCI) 1999 [1], “whole grains include intact, crushed, cracked, and flaked kernels containing starchy endosperm, germ, and bran in the same proportions as the intact kernel”. However, in 2006, pseudo-cereals were included in the category of whole grains [2] due to the fact that they are used in the same traditional way as cereals and have a macronutrient composition that is largely similar to that of cereals. Whole grain intake, rather than that of refined grains, is known to have numerous health benefits, many of which are attributed solely to the presence of dietary fiber [3]: first, by releasing indigestible fiber, which affects the composition and activity of the gut microbiota; second, by providing substrates like resistant starch and non-starch polysaccharides. However, other components, like phenolic acids, are also likely involved given that they can be metabolized into useful metabolites of microbiota [4]. Previous observational studies have found an inverse association between the intake of whole grains and markers of inflammation [5,6,7]; however, the data from existing studies are inconsistent [8,9]. Additionally, different studies have been conducted to investigate the association between refined grain consumption and inflammatory markers. However, the evidence is inconsistent regarding the consumption of refined grains and health outcomes; the majority of research has shown that consuming refined grains has either negative or neutral effects on inflammation and disease outcomes [10,11,12]. Furthermore, refined grains have also been linked to unhealthy eating habits that increase the likelihood of developing certain diseases [13,14].
To date, several epidemiological studies have been conducted on the association between whole grain intake and several chronic diseases, such as inflammation [4,5,6,7,15]. According to Browning et al. [16], their study on whole grains and inflammation makers found that inflammatory markers like C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factors (TNF) can be used to assess the anti-inflammatory properties of whole grains and might be downregulated as an inflammatory response [17]. According to this study, the association between inflammation and illness may be larger than previously thought since some inflammatory indicators, like CRP, have significant within-individual variability. Most observational and interventional studies have focused on the inflammatory biomarkers CRP, TNF-α, TNF-α receptor 1 and 2, IL-6, fibrinogen, and IL-1β. These biomarkers are known to be associated with inflammation, which can lead to the development of neurodegenerative diseases, type 2 diabetes (T2D), joint disorders, cardiovascular disease (CVD), cancer, and allergies [18,19,20]. In particular, IL-6, an acute-phase protein produced by the liver in response to IL-6, appears to be the most studied inflammatory biomarker in studies investigating the influence of whole grains on inflammation [21,22]. This recognition has led researchers to investigate the association between whole grain intake and inflammatory process, aiming to reduce the risk of several chronic diseases [17]. On the other hand, many anti-inflammatory drugs that are commonly used might have side effects [23]. For these reasons, slowing down the inflammatory process becomes critical. Whole grain dietary fiber and phenolic acids have attracted scientific attention as they play a significant role in the reduction of the risk of inflammation with no side effects. While there may never be a single path towards the prevention of inflammation, it is possible that the long-term consumption of whole grains as part of a generally healthy dietary pattern may significantly reduce the development of inflammation and associated diseases. As a result, the purpose of this review is twofold: first, it discusses whole grain dietary fiber and phenolic acids and highlights their potential in lowering the risk of inflammation and other diseases; second, it examines the health benefits of the associations between whole grain intake and biomarkers of inflammation, along with the underlying mechanisms. In summary, this paper explores how whole grains may help to reduce inflammatory markers, as the scientific evidence about the anti-inflammatory properties of whole grains is encouraging. Recent evidence suggests that dietary fiber together with phenolic acids may be more beneficial for health than individual components. However, while there is promising evidence for the anti-inflammatory properties of whole grains, further studies are needed to understand their effects fully.

2. Materials and Methods

In the current study, we explored and summarized the literature on dietary fiber and phenolic acids in targeted whole grains (Table 1). Then, we examined the literature that was recently published on the intake of whole grains and the development of inflammation. Human studies, observational studies, and intervention studies were searched on PubMed and Google Scholar. The major keywords for the literature were whole grains, dietary fiber, arabinoxylan, β-glucan, phenolic compounds, hydroxycinnamic acids, hydroxybenzoic acids, gut microbiota, and inflammation. Relevant data that have been published in English in reputable peer-reviewed publications were included for discussion. Finally, all materials accessible in the form of books and conference abstracts, and unpublished materials, were excluded.

3. Whole Grain Dietary Fiber and Phenolic Acids and Their Health Potential

3.1. Dietary Fiber

According to the definition of dietary fiber given by Health Canada, “dietary fiber is a form of carbohydrate, which are classified according to their degree of polymerization, naturally occurring in all plants that are not digested and absorbed by the small intestine” [24]. Dietary fiber can be further classified based on its water solubility, with the two types being soluble dietary fiber (SDF) and insoluble dietary fiber (IDF) [25]. IDF is present in plants as a structural cell wall component made up of cellulose, insoluble hemicelluloses, and lignin, while SDF is made up of a range of non-cellulosic polysaccharides and oligosaccharides [26]. Hemicellulose, a non-cellulosic component of cell walls, made up of heterogenic polysaccharides, is a common form of DF found in grains [27]. Hemicellulose molecules are broadly categorized into four types: xylans, xyloglucans, glucomannans, and mixed linkage β-glucans [28]. Hemicelluloses can be soluble or insoluble depending on their size and structural characteristics (e.g., side chain substitutions and intermolecular crosslinks) [29]. About 70% of the total dietary fiber composition is made up of arabinoxylan (AX) and 20% is made up of mixed linked β-glucan. Consequently, AX is made up of four structural components: non-substituted, mono- and di- substituted Xyl, and O-2 or O-3 [30]. The O-5 position of arabinose residues can be used to esterify ferulic acid. These ferulic acid structures can form links between AX chains, increasing the molecular weight of the compound while lowering its water extractability.
As shown in Table 2, rye has higher dietary fiber content as compared to corn, sorghum, millet, and triticale, ranging from 14 to 21% dry matter [31,32,33,34,35] (Table 2). Rye includes four types of dietary fiber: AX, cellulose, fructan, and β-glucan. The endosperm cell walls contain AX, which accounts for 45% of the total fiber content (i.e., 45% of total dietary fibre content) [36]. Although both rye and quinoa contain AX, the amount and solubility of AX in rye is greater than that in millet [27].
Among cereal grains, rye contains the largest amount of fructans. Fructans are a form of soluble dietary fiber made up of β-D-fructofuranosyl units that may or may not have a terminal glucose residue [34]. Rye fructans can be either linear or branching in structure. The degree of fructan polymerization in rye often varies from 2 to 60 [37]. The amount of dietary fiber in rye varies according to its location within the kernel. The inner endosperm has less dietary fiber (12%), whereas the outer endosperm and bran part contain between 22 and 38% dietary fiber, respectively [38]. The higher levels of dietary fiber found in rye’s outer kernel layers demonstrate the benefits of consuming whole grains. Corn’s dietary fiber composition ranges between 3.7 and 19.9% on a dry matter basis, with IDF accounting for the largest fraction, namely 3 to 14 g/100 g (Table 2) [32,35,39,40,41]. In corn bran, cellulose and hemicellulose make up the majority of the IDF components [41,42]. The TDF of sorghum ranges from 1.5 to 12% [43,44,45], millet has content of 13–14% [46,47,48], and triticale has content of 14–15% on a dry matter basis in terms of g/100 g [38,49,50,51,52].
Table 2. Content of total, soluble, and insoluble dietary fiber in targeted grains, g/100 g.
Table 2. Content of total, soluble, and insoluble dietary fiber in targeted grains, g/100 g.
Whole GrainTDFIDFSDFReferences
Rye (Secalecereale L.)15.2–20.911.1–15.93.7–4.5[31,32]
14.7–20.910.8–15.93.4–4.6[33,34,35]
Corn (Zea mays L.)3.7–8.63.1–6.10.5–2.5[39,40]
13.1–19.611.6–14.01.5–3.6[32,35,41]
Sorghum (Sorghum bicolor)7.55–12.36.52–7.901.05–1.23[43,44,45]
Millets (Eleusine coracana (L.) Gaertn.)13.0–13.812.5–13.50.52–0.59[46,47,48]
Triticale (Triticosecale Wittmack)14.56–8-[38,49,50]
14.612.00.2–1.3[51,52]
Quinoa (Chenopodium quinoa Willd.)7.0–26.5--[53,54]
11.6–21.69.9–12.20.4–2.9[55,56,57]
Quinoa is a pseudo-cereal that has a long history of use as a food component and has some very interesting nutritional properties. In the past 10 years, pseudo-cereals have become increasingly popular as ingredients in gluten-free goods [58]. The dietary fiber content of quinoa varies from 7 to 27%, with more than 30% being soluble dietary fiber [53,54,55,56,57] (Table 2). However, Alonso-Miravalles et al. reported that quinoa contains 11–19% of TDF [57]. The TDF content in this study was consistent with that found in other studies of quinoa, e.g., 10.4% [54], 11.7% [59], and 12.7% [60]. Compared to these studies, Alvarez-Jubete et al. [58] reported slightly higher values for TDF, namely 14.2%. Additionally, Nascimento et al. [59] revealed that pseudo-cereals contain seven times more fiber than other grains, like rice. Furthermore, the majority of the dietary fiber in these pseudo-cereals, as determined by a monosaccharide analysis of dietary fiber taken from samples of quinoa and amaranth, is made up of galacturonic acid, arabinose, xylose, glucose, and galactose. The main components of quinoa are soluble and insoluble dietary fiber, and it has been categorized as pectic polysaccharide [61] based on the monosaccharide composition and linkage analyses. Xyloglucans are the second most abundant form of dietary fiber contained in quinoa whole grains.
In summary, whole grain cereals and pseudo-cereals contain a wide variety of dietary fiber types. The dietary fiber and phenolic acid composition of whole grains is very varied across different grains. As seen in Table 2, among the above-studied whole grains, quinoa contains the highest content of total dietary fiber. Rye is particularly rich in AX, while quinoa and millet are known for their health benefits, associated with their main dietary fiber, i.e., β-glucan. One of the primary impacts of soluble dietary fiber is an increase in intestinal viscosity. Insoluble dietary fiber, on the other hand, absorbs more water and helps with feces bulking. It has been found that quinoa has the highest levels of dietary fiber, ranging from 7 to 27%, while sorghum has the lowest levels of dietary fiber among cereals, ranging from 7 to 13%. The rankings are variable in other cereals. Quinoa, rye, corn, triticale, millet, and sorghum have the most TDF, in descending order, as shown in Table 2. In a few studies, both SDF and IDF in triticale and quinoa were undetected. The intake of whole grain dietary fiber can reduce the risk of chronic non-communicable diseases [62,63,64,65,66,67]. Diets rich in whole grains play a significant role in lowering the risk of inflammation [6,7,8,9,19,35]. Additional experimental trials are required to verify the composition of TDF, IDF, and SDF in various whole grains.

3.2. Health Potential

The bran is a grain’s nutrient storehouse. The whole grain bran’s chemical composition is very complex. The regular consumption of whole grain dietary fiber may help to lower the risk of numerous diseases [64]. In addition to dietary fiber, the bran also contains a number of nutrients, such as protein, vitamins, minerals, and fats, which have been demonstrated to have a wide range of biological activity and other health benefits in populations that consume cereal-grain-based diets [66,68]. However, choosing a good source becomes difficult due to their wide range of physicochemical properties. One of the major components found in the whole grain bran is dietary fiber. The benefits of dietary fiber for human health have been supported by extensive research conducted over the last three decades [65,67]. The main role of β-glucan in the diet is to decrease blood lipids, specifically serum total and LDL cholesterol, and both of these effects have long-term health advantages [69] (Table 3). According to the authors, it was found that the average cholesterol reduction was 4.4%. Notably, the test samples for the meta-analysis included intact whole oats and oat bran, and the data were obtained from 23 trials that used less than 10 g of dietary fiber daily. Furthermore, whole grain β-glucan has several health benefits. [70], including lowering blood cholesterol and glucose levels, decreasing the glycemic index, prebiotic effects, and improving satiety, all of which aid in the long-term management of heart disease and other chronic non-communicable diseases, as shown in Table 3 [71,72,73,74,75,76,77,78,79,80,81,82,83].
The consumption of whole grain AX has been found to enhance lipid metabolism by lowering the LDL cholesterol levels in the blood, improve colon health by lowering the cancer risk, and improve glycemic management by lowering blood glucose levels [72,73]. AX has been shown in studies to inhibit small intestinal transit, limit starch availability to digestive enzymes, and slow the rate of lumen-to-cell glucose diffusion. Any of these factors might contribute to decreased glucose absorption, hence reducing the postprandial glycemic response [74]. The European Food Safety Authority has verified the health claim that AX intake decreases the rise in glucose after a meal [75]. The significant intake of dietary fiber helps individuals to lose weight and enhances blood glucose levels, immune function, and serum cholesterol levels. It also reduces the likelihood of developing several chronic diseases, including CVD and T2D, as well as certain cancers [67,80,81,82]. Recent research on the health effects of whole grains, particularly their bioactive components, has highlighted their potential as a functional food that can lower the risk of multiple chronic diseases [81].
Table 3 summarizes the functional compounds together with their locations in the grain fractions. The findings of several studies show the relationship between the health benefits of cereal-based foods, such as arabinoxylan, β-glucan, and other types of dietary fiber [71,72,73,74,75,76,77,78,79,80,81,82,83]. Numerous studies have been conducted throughout the years to determine the health advantages of the dietary fiber found in cereals and pseudo-cereals. While the specific effects of many other dietary fiber types remain under investigation, the intake of some forms, including β-glucan, has been recommended due to their documented health advantages. It is challenging to find conclusive proof of the health benefits of dietary fiber in lowering the risk of chronic diseases, since these advantages are connected to several factors. Additionally, the amount of dietary fiber in grains varies greatly. It is yet unclear, though, to what extent the dietary fiber included in whole grains contributes to these health advantages. Thus, additional study of the compositions of different types of whole grains, as well as their health advantages, is required to translate the science behind these positive impacts into useful information.

3.2.1. Phenolic Acids

Phenolic compounds are identified by the presence of one or more aromatic rings connected by one or more hydroxyl groups. Phenolic acids include benzoic and cinnamic acid derivatives. In general, “phenolic acids” are phenols having a single carboxylic acid. However, when defining plant metabolites, it refers to a distinct class of organic acids. These naturally occurring phenolic acids have two different carbon frameworks: hydroxycinnamic and hydroxybenzoic. Although the underlying structure remains the same, the amounts and positions of the hydroxyl groups on the aromatic ring determine the variety.
In plants, phenolic acids are formed by shikimic acid via the phenylpropanoid pathway, as byproducts of the monolignol pathway, and as the breakdown products of cell wall polymers and lignin in vascular plants [84]. Grains contain three different forms of phenolic acids, conjugated, free, and bound, with the binding form predominating [85,86]. They are typically found in the bran and the embryo cell walls of cereal kernels [69,71]. Hydroxycinnamic acids are aromatic carboxylic acids with a C6–C3 structure. Ferulic, p-coumaric, caffeic, and sinapic acids are among the most common hydroxycinnamic acids found in grains (Table 4). Hydroxybenzoic acids have a C6–C1 structure, and p-hydroxybenzoic, gallic, vanillic, and syringic acids are abundant in grains. It has been demonstrated that hydroxycinnamic acids are more prevalent in plants than hydroxybenzoic acids [87,88]. Whole grains include phenolic acids such as ferulic, vanillic, caffeic, syringic, and p-coumaric acids [68,88,89]. Hydroxycinnamic acids are generated in a variety of plant foods, including coffee beans, tea, maté, berries, citrus, grapes, spinach, beetroots, artichokes, potatoes, tomatoes, and cereals [90]. Cinnamic-related compounds have been shown to have anticancer, anti-tuberculosis, antimalarial, antifungal, antibacterial, antiatherogenic, and antioxidant properties. There are several cinnamic acid isoforms found in nature, with trans-CA (trans-3-phenyl-2-propenoic acid; t-CA) being the most common. Because of its low toxicity, t-CA has been widely employed as an antibacterial/antifungal component in medicine. Furthermore, t-CA is present in triticale, barley, oat, rye, rice, and maize, sorghum, and millet, with millet and quinoa having undetectable levels [91,92,93]. The following literature will cover the composition of phenolic acids, including derivatives of benzoic and cinnamic acids in whole grains, as they are present in the most widely eaten grains. Furthermore, the significance of these phytochemicals to the health advantages of whole grain consumptions is studied.
In Table 5, we present eight phenolic acids in targeted cereal grains, demonstrating that ferulic acid is the most abundant phenolic acid in cereals. It is the product of phenylalanine and tyrosine metabolism and is found primarily in the cell walls of rye, triticale [91], corn [94], sorghum [95], millet [96,97,98], and quinoa [99,100]. According to Table 5 the average ferulic acid (4-hydroxy-3-methoxycinnamic acid; FA) content of these grains ranges from 46.2 to 827.2 g/g dry weight, with rye and millet having the highest levels and triticale having the lowest. p-Coumaric acid (3-(4-hydroxyphenyl)-2-propenoic acid; p-CA) has been found in rye [91], corn and triticale [101], millet [97], sorghum [95], and quinoa [100]. The range of average content of p-coumaric acid in grains ranges from 43.6 g/g dry weight in sorghum to 340.5 µg/g in corn. Caffeic acid(3,4-dihydroxycinnamic acid) is typically found in foods as an ester with quinic acid to create chlorogenic acid. Caffeic acid can be found in rye, corn and triticale [91], millet and sorghum [95], and quinoa [100]. Sorghum has an average value of 4.6 µg/g dry weight; while sorghum has content of 32.1 µg/g. Sinapic acid (4-hydroxy-3, 5-dimethoxy cinnamic acid; SA) is prevalent in several plants, including rye [91,102], corn and triticale [91,101,103], sorghum [95], and millet [96]. The average content of sinapic acid in cereal grains varies from 8.22 to 94.2 µg/g sorghum and millet, whereas it is undetected in quinoa.
Hydroxybenzoic acids are phytochemicals found in various diets. It should be noted that the circulating hydroxybenzoic acids in humans can be the absorbed products of bacterially mediated polyphenol metabolism in the lower intestine [105,106]. This section discusses the widely discovered hydroxybenzoic acids in grains, namely p-hydroxybenzoic acid, gallic acid, vanillic acid, and syringic acid. p-Hydroxybenzoic acid is present in rye, corn and triticale [91], sorghum and millet [101], and quinoa [100]. The average amount of p-hydroxybenzoic acid ranges 3.0 µg/g in millet to 36.2 µg/g in sorghum. Gallic acid is found in rye, corn and triticale [91], sorghum [95], millet [96,97], and quinoa [100]. Its presence has not been reported in quinoa, and the greatest amount among grains was found in triticale, at 333.7 µg/g. Vanillic acid has been detected in rye, corn, and triticale [91], sorghum [105], millet [103], and quinoa [100]. The average concentration varies from 10.3 µg/g in corn to 446.0 µg/g in triticale. Syringic acid has been found in rye [91], corn and triticale [101], sorghum [95], and millet [104]. The average content of syringic acid is highest in triticale 173.2 µg/g and lowest in rye 6.3 µg/g, whereas it is undetected in quinoa.
In summary, regarding hydroxycinnamic acids and hydroxybenzoic acids (Table 5), ferulic acid is the most abundant in all grains except corn and triticale. In corn, ferulic acid is ranked second and p-coumaric acid ranks highest; however, in triticale, ferulic acid is ranked fifth, with vanillic acid, gallic acid, syringic acid, and p-coumaric acid being the most prevalent in triticale, respectively. In buckwheat, vanillic acid and gallic acid are predominant, in descending order. The ranking becomes variable for the rest of the phenolic acids within grains. The greatest total content of hydroxycinnamic acids and hydroxybenzoic acids, in descending order, is found in triticale, rye, corn, millet, sorghum, and quinoa; for the four hydroxycinnamic acids, the order is rye, corn, millet, triticale, sorghum, and quinoa; and in the four hydroxybenzoic acids, it is triticale, corn, millet, sorghum, quinoa, and rye. Remarkably, all grains except triticale have a ratio of hydroxycinnamic acids to hydroxybenzoic acids greater than 1. These comparisons suggest that each grain prefers one phenolic acid synthesis pathway to the others, leading to a unique phenolic acid profile. Quinoa appears to have significantly fewer phenolic acids than other grains, most likely as a result of their low synthesis. To validate these findings, further research and discussion are needed.

3.2.2. Health Potential

Epidemiological evidence suggests that phenolic acids have remarkable health-promoting impacts on chronic diseases, such as anti-inflammatory, antioxidant, antidiabetic, anticarcinogenic, and others (Table 6). One important function of phenolic acids is their ability to prevent cancer by preventing normal cell transformation, tumor growth, angiogenesis, and metastasis, all of which are factors that contribute to the development and spread of cancer. Moreover, phenolic acids promote the production of proteins that limit tumor growth, including phosphatase, p53, and the tensin homolog PTEN [107]. Several investigations have demonstrated that p-coumaric acids have antibacterial, anti-inflammatory, and anticancer properties [108,109,110]. For instance, Janicke et al. [110] found that p-coumaric acid inhibited the growth of Caco-2 colon cancer cells in the cell cycle, hence protecting against the development of colon cancer. Feruloyl-L-arabinose reduced lung cancer cell penetration, motility, and the formation of reactive oxygen species. Other phenolic acids, such as ferulic, feruloyl-L-arabinose, and p-coumaric, have also been examined in various cell lines for their anti-inflammatory, anticarcinogenic, antihypertensive, and antidiabetic potential [111,112,113,114]. According to Fahrioğlu et al. [112], ferulic acid displayed anticancer properties via influencing the cell cycle, invasion, and apoptotic behavior of MIA PaCa-2 cells. In addition, Eitsuka et al. [115] investigated the anticancer properties of ferulic acid against cancer cell proliferation; the authors found that the combination of the two compounds inhibited the proliferation of MCF-7, PANC-1, and DU-145 cells more effectively than individual ones alone. Moreover, numerous studies have shown that consuming whole grains rich in phenolic acids protects against a number of cardiovascular and blood-circulation-related diseases, including caffeic acid, while also improving insulin resistance, plasma triglyceride levels, and platelet function, demonstrating anticarcinogenic and antimutagenic properties [116].
Furthermore, no comprehensive investigation on the biological activity of sinapic acid can be found. A literature search revealed the existence of both free and ester forms of sinapic acid, with some examples of esters being sinapoyl esters, sinapine (sinapoylcholine), and sinapoyl malate [117]. Spices, citrus and berry fruits, vegetables, cereals, oilseed crops, and vegetables are among the edible plants that contain the phytochemical sinapic acid [118,119]. Sinapic acid has been investigated and documented in relation to a number of clinical conditions, including infections, oxidative stress [120], inflammation [121], cancer [122], T2D [123], neurodegeneration [124], and anxiety [125]. Studies have also been conducted on the acetylcholinesterase inhibition [126,127], antimutagenic [128], and antioxidant activity [129] of a few sinapic acid derivatives, including sinapine, 4-vinylsyringol, and syringaldehyde. In regard to p-hydroxybenzoic acid, we examined the antithrombogenic, anticoagulation, and inhibitory effects of protocatechuic acid, isovanillic acid, and 4-hydroxybenzoic acid, which all function as antithrombotic and anticoagulant agents [130,131]. However, there are no studies on how these substances affect blood cell viability or their inhibitory effects on fibrin clot formation, plasma recalcification, or the enzymatic activity of procoagulant proteases or fibrinoligases. DU-145 human prostate carcinoma cells and human leukemia (HL)-60 cancer cells are two examples of cancer cell types on which gallic acid has been shown to have a strong anticancer impact in a number of studies [132,133]. Furthermore, human epidermoid carcinoma (A431) skin cancer cells are not able to proliferate when methyl gallate is present [112,134]. In addition, it has been demonstrated that phenolic acids can be considered excellent antioxidants that are capable of neutralizing excessive damage to the body produced by free radicals and chronic conditions. The antioxidant capacity of hydroxybenzoic acids is centered on phenolic hydroxyl. In addition, methoxy and carboxy groups have a significant impact on phenolic acids’ antioxidant capabilities. They have an important role in the prevention of Alzheimer’s and Parkinson’s diseases, both of which are neurological illnesses, as well as vascular dementia and cerebrovascular insufficiency syndromes [135,136,137]. They also have antidiabetic, anticancer, cardioprotective, and anti-inflammatory properties [138]; see Table 5.
Table 6. Hydroxycinnamic acids and hydroxybenzoic acids and their health potential.
Table 6. Hydroxycinnamic acids and hydroxybenzoic acids and their health potential.
Phenolic AcidHealth PotentialReferences
p-Coumaric acidAntimicrobial, Anti-inflammatory, anticancer[108,109,110]
Ferulic acidAnticancer, antihypertensive, antidiabetes, anti-inflammatory[111,112,113,114,115]
Caffeic acidAntimutagenic, anticarcinogenic [116]
Sinapic acidAntioxidative, anti-inflammatory, anticancer, antidiabetic, anti-neurodegeneration, anti-anxiety[120,121,122,123,124,125]
p-Hydroxybenzoic acidAntithrombotic and anticoagulant[130,131]
Gallic acidAnticancer, HCV inhibition, antibacterial[132,133,134]
Vanillic acidAlzheimer’s disease and Parkinson’s disease, neurological disorders, vascular dementia, anti-inflammatory, and cerebrovascular insufficiency states[135,136,137]
Syringic acidAntidiabetic, anticancer, cardioprotective, anti-inflammatory[138]
Table 6 summarizes the phenolic acids found in grains and their health potential. With regard to p-hydroxybenzoic acid intake, several epidemiological studies support its protective effects against bacterial disorders, cardiovascular disease, type 2 diabetes, neurodegenerative diseases, and cancer. Numerous studies have been performed to examine the anti-platelet aggregation and antithrombotic activity of isovanillic acid and p-hydroxybenzoic acid, which act as antithrombotic and anticoagulant agents; however, no research has been conducted on how these compounds affect the viability of blood cells or how they inhibit the development of fibrin clots, the enzymatic activity of procoagulant proteases or fibrinoligases, and plasma recalcification. Furthermore, there is no extensive research on the biological properties of sinapic acid in the literature. Moreover, there is a lack of comprehensive literature regarding the biological characteristics of sinapic acid. This short review article summarizes these findings so that the scientific community may focus more on the biological properties of sinapic acid. Furthermore, cereal grains’ phenolic compounds have been shown to inhibit Parkinson’s and Alzheimer’s disease, as well as having anti-analgesic, anti-allergic, cardioprotective, and antidiabetic properties. As a result, phenolic compounds are considered to be beneficial natural bioactive and nutraceutical agents that can be used to prevent or inhibit a number of chronic non-communicable conditions, including inflammation.

4. Effect of Consuming Whole Grains on Inflammatory Active Components

4.1. Evidence from Epidemiological Studies

Epidemiological data strongly support the findings that the consumption of whole grains may reduce the risk of inflammation [4,5,6,7,15,21,22,23], as well as being beneficial in several other diseases, like coronary heart disease, CVD, T2D, and cancer [18,19,20,63,139]. Several studies support the role of whole grain dietary fiber and phenolic compounds in inflammation [81,83,111,121,138]. Research suggests multiple mechanisms of action, which remain unclear. The significance of subclinical inflammation is increasingly attracting attention in the literature as a common denominator in most disease processes [140,141].
In this regard, Xu et al. [142] collected data from different randomized controlled trial studies to investigate the relationship between whole grain intake and circulating inflammation markers. This meta-analysis included data on 838 individuals from nine RCTs. The findings of these analyses revealed that alterations in the inflammatory markers CRP, IL-6, TNF-α, and IL-1β were negatively correlated with higher whole grain intake intake (standardized mean difference, 0.16; 95% confidence interval, 0.02–0.30. Furthermore, whole grain consumption was found to be inversely associated with a significant decrease in the levels of IL-6 (standardized mean difference, 0.19; 95%CI, 0.03–0.36) and CRP (standardized mean difference, 0.29; 95%CI, 0.08–0.50). Moreover, a substantial reduction in the levels of CRP and IL-6 was observed to be negatively correlated with whole grain intake. A meta-analysis of 13 trials and 466 individuals revealed that the consumption of whole grains led to a significant increase in blood concentrations of hs-CRP and IL-6, but had no significant effect on TNF-α levels [143].
Recently, Zamaratskaia et al. [144] conducted an intervention trial study on the effect of a whole grain diet on low-grade inflammatory biomarkers in men with prostate cancer. This study examined the effects of whole grain/bran rye consumption on low-grade inflammation and endothelial function biomarkers in men with prostate cancer. In a randomized crossover design, seventeen men with untreated, low-grade prostate cancer consumed 485 g of whole grain and bran products or refined wheat products with added cellulose daily. Fasting blood samples were collected before and after two, four, and six weeks of treatment. In comparison to diets containing refined wheat products, males with prostate cancer who consumed whole grains including rye and rye bran had lower levels of the inflammatory biomarkers TNF receptor 2, E-selectin, and endostatin. A beneficial impact of whole grain intake and subclinical inflammation was reported by [145], when 50 obese participants (body mass index > 30 kg/m2) consumed whole-grain-rich meals for a period of 12 weeks. The authors discovered that the CRP concentrations in the whole grain group had significantly decreased, by 38%, at the end of the intervention, while the concentrations in the refined grain group remained unchanged [145].
Summarizing these benefits, numerous systematic reviews and meta-analyses have been published that validate these findings and are now collected into “umbrella reviews” [146,147,148]. Whole grains have been shown in studies to enhance glucose kinetics, reduce peripheral insulin resistance, and lower inflammation [6,7,142,149]. However, it should be noted that whole grain consumption may not be the only factor contributing to health in general; other factors include smoking less, drinking less alcohol, and being more physically active [150,151].

4.2. Dietary Fiber

Whole grains are high in SDF, particularly β-glucan, which is considered to be a major active component of whole grains that alters and stimulates the gut bacteria (Figure 1). Increased dietary fiber consumption has been shown to provide a number of health benefits, including anti-inflammatory properties. Additional evidence suggests a direct link between carbohydrate-rich and dietary-fiber-deficient diets in the development of inflammation, lending support to the important role of dietary fiber in inflammation [152]. Furthermore, Qi et al. [153] investigated the relationship between whole grain dietary fiber and inflammatory markers and found an inverse correlation between the highest 18% and lowest 8% quintiles of cereal fiber consumption and lower levels of CRP and TNF receptor 2. Whole grain products with β-glucan have also been investigated for their impacts on ulcerative colitis [81], a severe inflammatory bowel disease characterized by gastrointestinal inflammation and induced by persistent or recurrent immune system activation, and the upregulation of pro-inflammation markers, such IL-1β, has been observed in animal models [82]. Most research on colitis focuses on the pro-inflammatory biomarker IL-1β, which is largely generated by lamina propria monocytes and macrophages that infiltrate the colitis mucosa [83]. In another comparable study, to evaluate their anti-inflammatory properties, male Wistar rats were fed diets containing two whole grain barley cultivars with varied dietary fiber and β-glucan content; it also studied the solubility of dietary fiber [76]. The authors discovered that the consumption of barley may reduce the risk of inflammation, as shown by lower plasma levels of LPS-binding protein and monocyte chemoattractant protein 1.
In a study involving 80 mice, Liu et al. [77] found that oat β-glucan might prevent colitis caused by dextran sodium sulfate. This study found that the consumption of oat β-glucan at 500 and 1000 mg/kg lowered the aberrant mRNA expression of inflammatory biomarkers, including TNF-α, IL-6, and IL-1β. In contrast, Wilczak et al. [154] evaluated the influence of two forms of β-glucan, high and low, on 72 male Sprague-Dawley rats with LPS-induced enteritis. This study discovered that β-glucan, especially low-molecular-weight oat β-glucan, has potent anti-inflammatory properties, as demonstrated by anti-inflammatory markers, pro-inflammatory IL-12, TNF-α, and the profiles of both the lamina propria and intraepithelial lymphocyte populations that inhabit the colon tissue.
As previously mentioned, dietary fiber is likely to affect the diversity of the colonic microbiota and the production of short-chain fatty acids (SCFAs). Additionally, butyrate is known to mediate inflammatory pathways; dietary fiber has an impact on the inflammatory status both systemically and inside the colon, since butyrate is known to mediate the inflammatory pathways. Subsequent investigations should focus on the involved mechanisms. It will be challenging to determine the precise mechanisms that mediate dietary fiber’s anti-inflammatory effects, since dietary fiber has many potential benefits, several of which are discussed in this section, and because the mechanisms underlying these benefits are complex and may involve the colonic microflora. Thus, numerous strategies, such as prospectively designed randomized controlled trials and rodent-based mechanistic investigations, will be needed for future study.

4.3. Phenolic Compounds

Inflammation is an important biological reaction to any tissue damage. Pro-inflammatory cytokines are released by the immune system in response to any stimulation, including injury, infection, or irritation [155]. Pro-inflammatory cytokine overproduction, such as that of TNF-α and IL-1b, can cause major health conditions, such as allergies, cancer, joint problems, and cardiovascular disease. Therefore, it is essential to reduce the overproduction of these pro-inflammatory cytokines in order to prevent and control these diseases. Since ancient times, phenolic chemicals have been used to treat inflammation and associated diseases. To further understand the influence of whole grains on inflammation, numerous bioactive components of whole grains and their metabolites have been studied for their potential effects on inflammation indicators [17,156]. Although prior research has mostly focused on the presence of fiber in whole grains for its anti-inflammatory characteristics, recent findings indicate that the anti-inflammatory substances in whole grains extend beyond fiber [157,158]. Other bioactive compounds found in whole grains have also been linked to their anti-inflammatory properties. In this regard, [159] studied the anti-inflammatory activity of p-coumaric acid by assessing the TNF-α levels in arthritic rats’ synovial tissue. p-Coumaric acid possessed anti-inflammatory properties and decreased TNF-α expression. In addition, [111] reported that ellagic and caffeic acids have anti-inflammatory properties. Mice were fed both caffeic acid and ellagic acid at the ratio of 2.5 and 5.0% by mixing them into their usual food. The expression of inflammatory mediators was decreased upon the inclusion of these phenolic acids. In a high-fructose-diet-mediated metabolic alteration model, caffeic acid reduced pro-inflammatory cytokines such as serum IL-6, IL-8, and TNF-α, resulting in anti-inflammatory, anti-hyperglycemic, and anti-hyperlipidemia effects [18]. Interestingly, Ibitoye et al. [160] discovered that, via increasing NO bioavailability, caffeic acid positively modulated blood pressure in rats with cyclosporine-induced hypertension.
Whole grains contain avenantramides (AVAs), which are secondary metabolites. These polyphenolic compounds, which are found in the bran portion of oat grains and are crucial components of oat groats, have also been investigated in relation to inflammation. The three most prevalent AVAs in oats are esters of 5-hydroxyanthranilic acid with p-coumaric acid, ferulic acid, or caffeic acid. Oats’ phenolic compounds, including AVAs, have also been shown to have anti-inflammatory and antioxidant properties. It has been shown in both in vivo and in vitro investigations to significantly decrease the inflammatory response in the systemic circulation caused by exercise in women of all ages [161]. This study found that treatment with AVA reduced the levels of NFκB activation, CRP, IL-1β, IL-6, and neutrophil respiratory bursts, using a human aortic endothelium cell culture system. Liu et al. [162] investigated the anti-inflammatory and anti-atherogenic characteristics of oat AVAs. After subjecting human aortic endothelial cells to AVA pretreatment for a whole day, the amount of IL-1β-induced inflammation was notably decreased. Furthermore, Sur et al. [163] investigated the AVAs’ anti-inflammatory properties in human keratinocytes. According to the study findings, NF-κB-dependent luciferase activity was dramatically reduced by AVA treatment, which also resulted in a decrease in α-IL-8 release in keratinocytes treated with TNF-α.
Ex vivo studies have demonstrated the anti-inflammatory properties of phenolic acids and their metabolites in the circulation. Mateo Anson et al.’s study [164] examined the impact of phenolic acids and their metabolites on biomarkers associated with inflammation in eight healthy males. They were given a low-phenolic-acid diet for three days, followed by an overnight fast, and then they were given 300 g of either low-phenolic-acid regular wheat bread or high-phenolic-acid whole wheat bioprocessed bread. Following bread consumption, at 0, 1.25, 6, and 12 h, blood samples were taken and subjected to LPS incubation. After consuming bioprocessed wheat bread with a high phenolic acid concentration versus bread with low phenolic acid content, a comparison of several blood samples showed a considerably reduced pro-inflammatory to anti-inflammatory cytokine ratio.
In summary, studies on whole grains’ impacts on inflammation have shown conflicting results, most likely as a result of the various study methodologies and designs. For instance, several trials were less controlled than others, despite the fact that they maintained the participants’ weight, strictly monitored the food, and kept the examined dietary components consistent. Furthermore, the apparent impact of whole grains on inflammatory markers may have been influenced by the exclusion of biomarkers of adherence from some study designs. Additionally, although some research was performed on healthy people who were not likely to have a weak immune system or a high inflammatory status, it is possible that the participants who were preselected due to having a chronic disease or a high inflammatory status showed more noticeable changes. Therefore, in order to sufficiently prove the therapeutic efficacy of phenolic acids and establish their safety for human intake, more research and clinical trials are necessary.

4.4. Proposed Mechanism of Anti-Inflammatory Properties of Whole Grain Dietary Fiber and Phenolic Compounds and Involvement of Gut Microbiota

Whole grains’ potential to modulate inflammation has been attributed to SCFAs, which are byproducts of the microbial degradation of whole grain dietary fiber (Figure 1). The anti-inflammatory properties of whole grains may be partially attributed to the bioactive properties of SCFAs [77,153,154]. Whole grain consumption has been shown to enhance the concentration of Lachnospira, a producer of SCFAs, as well as the stool SCFA content, when compared to refined grain consumption [165]. SCFAs (butyrate, propionate, and acetate) in the blood and gastrointestinal tract can influence leukocyte activity and cytokine synthesis, which can reduce inflammation. Acting via signaling pathways like NF-κB and mitogen-activated protein kinase, cytokines are soluble regulatory signals and intercellular messengers that both trigger and limit inflammatory responses. When cytokines reach areas of inflammation, they eliminate microbial pathogens [166]. Although cytokines play a vital role in directing both the innate and adaptive immune responses to inflammation, an excessive amount can be harmful. Furthermore, the activity of histone deacetylase may be impacted by SCFAs. It has been demonstrated that histone deacetylase inhibitors decrease ex vivo reactions to pro-inflammatory stimuli, as well as the plasma levels of cytokines [167,168]. According to a number of recently published studies, the capacity of SCFAs to stimulate immune cells aids in the elimination of pathogens that cause inflammation and regulates the overproduction of cytokines and chemokines.
Numerous investigations have demonstrated the anti-inflammatory and antioxidant qualities of phenolic compounds [97,102,111,120,121,129,159]. Supplementation with phenolic acids has been shown significantly reduce the pro-inflammatory response to exercise-induced inflammation [161]. The authors revealed that treatment with phenolic acids reduced neutrophil respiratory bursts, CRP, IL-1β, and IL-6 levels, and NFκB activation; see Figure 1. Furthermore, Liu et al. [162] studied the impact of whole grain phenolic acids in a human aortic endothelial cell culture in terms of anti-inflammatory and anti-atherogenic properties. According to this study, endothelial cells treated with phenolic acids for 24 h showed significantly reduced IL-1β-induced inflammation. Additionally, Sur et al. [163] investigated the potential anti-inflammatory properties of phenolic acids in human keratinocytes. The results of this investigation showed that the phenolic acids significantly inhibited NF-κB-dependent luciferase activity and reduced IL-8 release in TNF-α-treated keratinocytes.
Whole grains may have some beneficial effects on the gut microbiome due to their ability to influence both the host metabolism and gut microbial ecology (Figure 1). Consequently, a number of nutritional studies have examined the effect of whole grains on inflammation, including the role of the gut microbiome. In addition, according to Lee et al. [169], whole grains have modulatory effects on inflammation markers; they also studied the changes in the populations of useful microbiota such as Lactobacillus and Bifidobacterium, as well as observing a lower abundance of the Bacteroides fragilis bacterial group in the cecum. Moreover, Vitaglione et al. [35] discovered a link between a significant decrease in the inflammatory marker TNF-α and an increase in Lactobacillus and Bacteroides spp. abundance. Furthermore, Martínez et al. [170] examined whether the gut microbiota was connected to the effect of whole grains on inflammatory markers. This study included 28 healthy adult mice that consumed 60 g of whole grain barley, brown rice, or a combination of the two, every day for four weeks. The findings of this investigation demonstrated a reduction in plasma IL-6 levels as well as a potential decrease in plasma hs-CRP levels. High-fat diet supplementation had the opposite effect on the alterations generated by the high-fat diet in mice and had a “prebiotic effect,” comparable to improving the number of Lactobacillus, Bifidobacterium, Akkermansia, and Bacteroides-Prevotella. Furthermore, combining whole grains and bran with a high-fat diet improved the amount of Roseburia spp., an essential butyrate-producing bacterium in the gut that may promote butyrate-dependent anti-inflammatory effects. Meanwhile, a high-fat diet reduced the levels of Enterobacteriaceae, which may have been connected to a reduction in LPS translocation and an improvement in gut barrier integrity, and such prebiotic actions may play a role in the anti-inflammatory and metabolic benefits. Thus, whole grains appear to regulate inflammation through different pathways. These beneficial actions might include the positive effects of dietary fiber, phenolic acids and their metabolites, and the microbial metabolites SCFAs (related to fiber). While some of these advantages are direct, others are due to prebiotic effects on gut bacteria, which convert important bioactive substances into more beneficial metabolites, influencing the biomarkers associated with inflammation.
Figure 1. Connections between whole grain dietary fiber and phenolic compounds and inflammation; role of gut microbiota, interferon gamma (IFN-ϒ), interleukin 1 beta (IL-1β), interleukin 6 (IL-6), inducible nitric oxide synthase (iNOS), lipopolysaccharide (LPS), nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), reactive nitrogen species (RNS), reactive oxygen species (ROS), and tumor necrosis factor alpha (TNF-α).
Figure 1. Connections between whole grain dietary fiber and phenolic compounds and inflammation; role of gut microbiota, interferon gamma (IFN-ϒ), interleukin 1 beta (IL-1β), interleukin 6 (IL-6), inducible nitric oxide synthase (iNOS), lipopolysaccharide (LPS), nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), reactive nitrogen species (RNS), reactive oxygen species (ROS), and tumor necrosis factor alpha (TNF-α).
Nutrients 16 01047 g001

5. Conclusions

This manuscript presents a comprehensive review of the composition and biological activity of whole grain dietary fiber and phenolic acids. As reviewed above, whole grains contain various types of dietary fiber and phenolic acids; however, different grains typically have a distinct dietary fiber and phenolic acid profile. The benefits of dietary fiber and phenolic acids from whole grains have been extensively studied throughout the years. The bran and germ, which are removed during the grain refinement process, contain the majority of the components that are beneficial to health. Emerging data suggest that whole grain consumption has benefits beyond basic nutrition, which is supported by epidemiological research revealing a protective impact of whole grains against inflammation. The anti-inflammatory activity may involve the impact of dietary fiber, microbial metabolites such as SCFAs, and phenolic acids. While some of these benefits are direct, others involve the prebiotic’s action on the gut bacteria, which convert essential bioactive compounds into more beneficial metabolites, hence influencing inflammatory biomarkers. Challenges appear in diverse areas; therefore, it is critical to determine which of these components may have the greatest protective action. Further research is needed to understand their effects fully, whether the bran, germ, dietary fiber, or specific phenolic acids associated with reducing the levels of inflammatory markers.
In general, whole grains contain both dietary fiber and phenolic acids. The modulatory effects of whole grains on inflammation might be exerted via several mechanisms, including the effects of dietary fiber and phenolic compounds and the role of the gut microbiota. While beyond the scope of the study, it is worth mentioning that the intestinal mycobiome and virome are also important. Candida of the gut has been studied in relation to many diseases and also with respect to dietary contributions. However, more direct evidence linking these mechanisms to the observed health outcomes would strengthen the argument.

Author Contributions

J.K. and P.G.: conceptualization, original draft preparation, and editing. M.T.R., Q.L. and K.L.: visualization and review. K.L.: supervision. All authors have read and agreed to the published version of the manuscript.

Funding

Financial support for this study was given by the following organizations: Henan University of Technology, 2021ZKCJ03; the Innovative Funds Plan; the National Natural Science Foundation of China, 32172259; the Key Research and Development Project of Henan Province, 231111111800; the Program for the Top Young Talents of Henan Associate for Science and Technology, 2021.

Data Availability Statement

All the data are already provided in the main manuscript.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in study design, the decision to publish and the preparation of the manuscript.

References

  1. AACCI. Definition of Whole Grain. 1999. Available online: http://www.aaccnet.org/definitions/wholegrain.asp (accessed on 15 February 2024).
  2. AACCI. 2006. Available online: http://www.aaccnet.org/definitions/pdfs/AACCIntlWholeGrainComments.pdf (accessed on 17 February 2024).
  3. Saleh, A.S.; Wang, P.; Wang, N.; Yang, S.; Xiao, Z. Technologies for enhancement of bioactive components and potential health benefits of cereal and cereal-based foods: Research advances and application challenges. Crit. Rev. Food Sci. Nutr. 2019, 59, 207–227. [Google Scholar] [CrossRef] [PubMed]
  4. Calabriso, N.; Massaro, M.; Scoditti, E.; Pasqualone, A.; Laddomada, B.; Carluccio, M.A. Phenolic extracts from whole wheat biofortified bread dampen overwhelming inflammatory response in human endothelial cells and monocytes: Major role of VCAM-1 and CXCL-10. Eur. J. Nutr. 2020, 59, 2603–2615. [Google Scholar] [CrossRef]
  5. Milesi, G.; Rangan, A.; Grafenauer, S. Whole Grain Consumption and Inflammatory Markers: A Systematic Literature Review of Randomized Control Trials. Nutrients 2022, 14, 374. [Google Scholar] [CrossRef] [PubMed]
  6. Sang, S.; Idehen, E.; Zhao, Y.; Chu, Y. Emerging science on whole grain intake and inflammation. Nutr. Rev. 2020, 78, 21–28. [Google Scholar] [CrossRef] [PubMed]
  7. Rahmani, S.; Sadeghi, O.; Sadeghian, M.; Sadeghi, N.; Larijani, B.; Esmaillzadeh, A. The effect of whole-grain intake on biomarkers of subclinical inflammation: A comprehensive meta-analysis of randomized controlled trials. Adv. Nutr. 2020, 11, 52–65. [Google Scholar] [CrossRef] [PubMed]
  8. Andersson, A.; Tengblad, S.; Karlström, B.; Kamal-Eldin, A.; Landberg, R.; Basu, S.; Åman, P.; Vessby, B. Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J. Nutr. 2007, 137, 1401–1407. [Google Scholar] [CrossRef] [PubMed]
  9. Roager, H.M.; Vogt, J.K.; Kristensen, M.; Hansen, L.B.S.; Ibrügger, S.; Mærkedahl, R.B.; Bahl, M.I.; Lind, M.V.; Nielsen, R.L.; Frøkiær, H.; et al. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: A randomised cross-over trial. Gut 2019, 68, 83–93. [Google Scholar] [CrossRef] [PubMed]
  10. Vanegas, S.M.; Meydani, M.; Barnett, J.B.; Goldin, B.; Kane, A.; Rasmussen, H.; Brown, C.; Vangay, P.; Knights, D.; Jonnalagadda, S.; et al. Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults. Am. J. Clin. 2017, 105, 635–650. [Google Scholar] [CrossRef] [PubMed]
  11. Taskinen, R.E.; Hantunen, S.; Tuomainen, T.P.; Virtanen, J.K. The associations between whole grain and refined grain intakes and serum C-reactive protein. Eur. J. Clin. Nutr. 2022, 76, 544–550. [Google Scholar] [CrossRef] [PubMed]
  12. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose–response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013, 28, 845–858. [Google Scholar] [CrossRef] [PubMed]
  13. Jones, J.M.; García, C.G.; Braun, H.J. Perspective: Whole and refined grains and health—Evidence supporting “make half your grains whole”. Adv. Nutr. 2020, 11, 492–506. [Google Scholar] [CrossRef] [PubMed]
  14. Sanders, L.M.; Zhu, Y.; Wilcox, M.L.; Koecher, K.; Maki, K.C. Whole grain intake, compared to refined grain, improves postprandial glycemia and insulinemia: A systematic review and meta-analysis of randomized controlled trials. Crit. Rev. Food Sci. Nutr. 2023, 63, 5339–5357. [Google Scholar] [CrossRef] [PubMed]
  15. Arabzadegan, N.; Daneshzad, E.; Fatahi, S.; Moosavian, S.P.; Surkan, P.J.; Azadbakht, L. Effects of dietary whole grain, fruit, and vegetables on weight and inflammatory biomarkers in overweight and obese women. Eat. Wei. Dis. Stud. Anor. Bul. Obes. 2020, 25, 1243–1251. [Google Scholar] [CrossRef] [PubMed]
  16. Browning, L.M.; Krebs, J.D.; Jebb, S.A. Discrimination ratio analysis of inflammatory markers: Implications for the study of inflammation in chronic disease. Metabolism 2004, 53, 899–903. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, W.Y.; Tan, M.S.; Yu, J.T.; Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann. Transl. Med. 2015, 3, 136. [Google Scholar] [PubMed]
  18. Agunloye, O.M.; Oboh, G.; Ademiluyi, A.O.; Ademosun, A.O.; Akindahunsi, A.A.; Oyagbemi, A.A.; Omobowale, T.O.; Ajibade, T.O.; Adedapo, A.A. Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: Mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats. Biomed. Pharmacother. 2019, 109, 450–458. [Google Scholar] [CrossRef] [PubMed]
  19. Lee, Y.M.; Han, S.I.; Song, B.C.; Yeum, K.J. Bioactives in commonly consumed cereal grains: Implications for oxidative stress and inflammation. J. Med. Food 2015, 18, 1179–1186. [Google Scholar] [CrossRef] [PubMed]
  20. Del Giudice, M.; Gangestad, S.W. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav. Immun. 2018, 70, 61–75. [Google Scholar] [CrossRef] [PubMed]
  21. Fink-Neuboeck, N.; Lindenmann, J.; Bajric, S.; Maier, A.; Riedl, R.; Weinberg, A.M.; Smolle-Juettner, F.M. Clinical impact of interleukin 6 as a predictive biomarker in the early diagnosis of postoperative systemic inflammatory response syndrome after major thoracic surgery: A prospective clinical trial. Surgery 2016, 160, 443–453. [Google Scholar] [CrossRef] [PubMed]
  22. Chen, W.W.; Zhang, X.I.A.; Huang, W.J. Role of neuroinflammation in neurodegenerative diseases. Mol. Med. Rep. 2016, 13, 3391–3396. [Google Scholar] [CrossRef] [PubMed]
  23. Hawkey, C.J.; Langman, M.J.S. Non-steroidal anti-inflammatory drugs: Overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003, 52, 600. [Google Scholar] [CrossRef] [PubMed]
  24. Health Canada. List of Dietary Fibre Reviewed and Accepted by Health Canada’s Food Directorate. 2020. Available online: https://www.canada.ca/en/health-canada/services/publications/food-nutrition/list-reviewed-accepted-dietary-fibres.html (accessed on 19 February 2024).
  25. Zeng, Z.; Liu, C.; Luo, S.; Chen, J.; Gong, E. The profile and bioaccessibility of phenolic compounds in cereals influenced by improved extrusion cooking treatment. PLoS ONE 2016, 11, e0161086. [Google Scholar] [CrossRef] [PubMed]
  26. Tian, M.; Pak, S.; Ma, C.; Ma, L.; Rengasamy, K.R.R.; Xiao, J.; Hu, X.; Li, D.; Chen, F. Chemical features and biological functions of water-insoluble dietary fiber in plant-based foods. Crit. Rev. Food Sci. Nutr. 2022, 64, 928–942. [Google Scholar] [CrossRef] [PubMed]
  27. Ciudad-Mulero, M.; Fernández-Ruiz, V.; Matallana-González, M.C.; Morales, P. Dietary fiber sources and human benefits: The case study of cereal and pseudocereals. Adv. Food Nutr. Res. 2019, 90, 83–134. [Google Scholar] [PubMed]
  28. Zhang, X.; Li, L.; Xu, F. Chemical characteristics of wood cell wall with an emphasis on ultrastructure: A mini-review. Forests 2022, 13, 439. [Google Scholar] [CrossRef]
  29. Van der Kamp, J.W.; Poutanen, K.; Seal, C.J.; Richardson, D.P. The HEALTHGRAIN definition of ‘whole grain’. Food Nutr. Res. 2014, 58, 22100. [Google Scholar] [CrossRef] [PubMed]
  30. Singh, A.; Eligar, S.M. Feruloylated oligosaccharides-emerging natural oligosaccharides for human health: Production, structural characterization, bioactive potential, and functional food applications. In Research and Technological Advances in Food Science; Academic Press: Cambridge, MA, USA, 2022; pp. 141–173. [Google Scholar]
  31. Gartaula, G.; Dhital, S.; Netzel, G.; Flanagan, B.M.; Yakubov, G.E.; Beahan, C.T.; Collins, H.M.; Burton, R.A.; Bacic, A.; Gidley, M.J. Quantitative structural organisation model for wheat endosperm cell walls: Cellulose as an important constituent. Carbohydr. Polym. 2018, 15, 199–208. [Google Scholar] [CrossRef] [PubMed]
  32. Fernando, B. Rice as a Source of Fibre. J. Rice Res. 2013, 1, e101. [Google Scholar] [CrossRef]
  33. Hansen, H.B.; Rasmussen, C.V.; Bach Knudsen, K.E.; Hansen, A. Effects of genotype and harvest year on content and composition of dietary fibre in rye (Secale cereale L.) grain. J. Sci. Food Agric. 2003, 83, 76–85. [Google Scholar] [CrossRef]
  34. Johnson, J.; Wallace, T. Whole Grains and Their Bioactives: Composition and Health; John Wiley & Sons: Hoboken, NJ, USA, 2019; pp. 169–208. [Google Scholar]
  35. Vitaglione, P.; Mennella, I.; Ferracane, R.; Rivellese, A.A.; Giacco, R.; Ercolini, D.; Gibbons, S.M.; La Storia, A.; Gilbert, J.A.; Jonnalagadda, S.; et al. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: Role of polyphenols bound to cereal dietary fiber. Am. J. Clin. Nutr. 2015, 101, 251–261. [Google Scholar] [CrossRef] [PubMed]
  36. Andersson, R.; Fransson, G.; Tietjen, M.; Åman, P. Content and molecular-weight distribution of dietary fiber components in whole-grain rye flour and bread. J. Agric. Food Chem. 2009, 57, 2004–2008. [Google Scholar] [CrossRef] [PubMed]
  37. Andersson, A.A.M.; Dimberg, L.; Åman, P.; Landberg, R. Recent findings on certain bioactive components in whole grain wheat and rye. J. Cereal Sci. 2014, 59, 294–311. [Google Scholar] [CrossRef]
  38. Rakha, A.; Åman, P.; Andersson, R. Dietary fiber in triticale grain: Variation in content, composition, and molecular weight distribution of extractable components. J. Cereal Sci. 2011, 54, 324–331. [Google Scholar] [CrossRef]
  39. Prasanthi, P.S.; Naveena, N.; Vishnuvardhana Rao, M.; Bhaskarachary, K. Compositional variability of nutrients and phytochemicals in corn after processing. J. Food Sci. Technol. 2017, 54, 1080–1090. [Google Scholar] [CrossRef] [PubMed]
  40. Joshi, D.C.; Chaudhari, G.V.; Sood, S.; Kant, L.; Pattanayak, A.; Zhang, K.; Fan, Y.; Janovská, D.; Meglič, M.; Zhou, M. Revisiting the versatile buckwheat: Reinvigorating genetic gains through integrated breeding and genomics approach. Planta 2019, 250, 783–801. [Google Scholar] [CrossRef] [PubMed]
  41. Arendt, E.K.; Zannini, E. Cereal Grains for the Food and Beverage Industries; Elsevier: Amsterdam, The Netherlands, 2013. [Google Scholar]
  42. De Santis, M.A.; Kosik, O.; Passmore, D.; Flagella, Z.; Shewry, P.R.; Lovegrove, A. Comparison of the dietary fibre composition of old and modern durum wheat (Triticum turgidum spp. durum) genotypes. Food Chem. 2018, 244, 304–310. [Google Scholar] [CrossRef] [PubMed]
  43. Verma, B.; Hucl, P.; Chibbar, R.N. Phenolic content and antioxidant properties of bran in 51 wheat cultivars. Cereal Chem. 2008, 85, 544–549. [Google Scholar] [CrossRef]
  44. Bach Knudsen, K.E.; Munck, L. Dietary fibre contents and compositions of sorghum and sorghum-based foods. J. Cereal Sci. 1985, 3, 153–164. [Google Scholar] [CrossRef]
  45. Wanjala, W.N.; Mary, O.; Symon, M. Optimization of protein content and dietary fibre in a composite flour blend containing rice (Oryza sativa), sorghum [Sorghum bicolor (L.) Moench] and Bamboo (Yushania alpine) shoots. Food Nutr. 2020, 11, 789–806. [Google Scholar]
  46. Jayawardana, S.A.S.; Samarasekera, J.K.R.R.; Hettiarachchi, G.H.C.M.; Gooneratne, J.; Mazumdar, S.D.; Banerjee, R. Dietary fibers, starch fractions and nutritional composition of finger millet varieties cultivated in Sri Lanka. J. Food Compos. Anal. 2019, 82, 103249. [Google Scholar] [CrossRef]
  47. Abah, C.R.; Ishiwu, C.N.; Obiegbuna, J.E.; Oladejo, A.A. Nutritional composition, functional properties and food applications of millet grains. Asian J. Agric. Food Sci. 2020, 14, 9–19. [Google Scholar] [CrossRef]
  48. Guo, X.X.; Sha, X.H.; Rahman, E.; Wang, Y.; Ji, B.; Wu, W.; Zhou, F. Antioxidant capacity and amino acid profile of millet bran wine and the synergistic interaction between major polyphenols. J. Food Sci. Technol. 2018, 55, 1010–1020. [Google Scholar] [CrossRef] [PubMed]
  49. Woźniak, A.; Soroka, M.; Stępniowska, A.; Makarski, B. Chemical composition of spring barley (Hordeum vulgare L.) grain cultivated in various tillage systems. J. Elem. 2014, 19, 597–606. [Google Scholar] [CrossRef]
  50. Bona, L.; Acs, E.; Lantos, C.; Tomoskozi, S.; Lango, B. Human utilization of triticale: Technological and nutritional aspects. Commun. Agric. Appl. Biol. Sci. 2014, 79, 139–152. [Google Scholar] [PubMed]
  51. Biel, W.; Kazimierska, K.; Bashutska, U. Nutritional value of wheat, triticale, barley and oat grains. Acta. Sci. Pol. Zootech. 2020, 19, 19–28. [Google Scholar] [CrossRef]
  52. Bacic, A.; Fincher, G.B.; Stone, B.A. Chemistry, Biochemistry, and Biology of 1–3 Beta Glucans and Related Polysaccharides; Academic Press: Cambridge, MA, USA, 2009. [Google Scholar]
  53. Srichuwong, S.; Curti, D.; Austin, S.; King, R.; Lamothe, L.; Gloria-Hernandez, H. Physicochemical properties and starch digestibility of whole grain sorghums, millet, quinoa and amaranth flours, as affected by starch and non-starch constituents. Food Chem. 2017, 233, 1–10. [Google Scholar] [CrossRef] [PubMed]
  54. Nowak, V.; Du, J.; Charrondière, U.R. Assessment of the nutritional composition of quinoa (Chenopodium quinoa Willd.). Food Chem. 2016, 193, 47–54. [Google Scholar] [CrossRef] [PubMed]
  55. Pulvento, C.; Riccardi, M.; Lavini, A.; Iafelice, G.; Marconi, E.; D’Andria, R. Yield and Quality Characteristics of Quinoa Grown in Open Field Under Different Saline and Non-Saline Irrigation Regimes. J. Agron. Crop Sci. 2012, 198, 254–263. [Google Scholar] [CrossRef]
  56. Miranda, M.; Vega-Gálvez, A.; Martínez, E.A.; López, J.; Marín, R.; Aranda, M.; Fuentes, F. Influence of contrasting environments on seed composition of two quinoa genotypes: Nutritional and functional properties. Chil. J. Agric. Res. 2013, 73, 6–7. [Google Scholar] [CrossRef]
  57. Alonso-Miravalles, L.; O’Mahony, J.A. Composition, protein profile and rheological properties of pseudocereal-based protein-rich ingredients. Foods 2018, 7, 73. [Google Scholar] [CrossRef]
  58. Alvarez-Jubete, L.; Arendt, E.K.; Gallagher, E. Nutritive value of pseudocereals and their increasing use as functional gluten-free ingredients. Trends Food Sci. Technol. 2010, 21, 106–113. [Google Scholar] [CrossRef]
  59. Nascimento, A.C.; Mota, C.; Coelho, I.; Gueifão, S.; Santos, M.; Matos, A.S.; Gimenez, A.; Lobo, M.; Samman, N.; Castanheira, I. Characterisation of nutrient profile of quinoa (Chenopodium quinoa), amaranth (Amaranthus caudatus), and purple corn (Zea mays L.) consumed in the North of Argentina: Proximates, minerals and trace elements. Food Chem. 2014, 148, 420–426. [Google Scholar] [CrossRef] [PubMed]
  60. Ando, H.; Chen, Y.C.; Tang, H.; Mayumi, S.; Watanabe, K.; Mitsunaga, T. Food components in fractions of quinoa seed. Food Sci. Technol. Res. 2002, 8, 80–84. [Google Scholar] [CrossRef]
  61. Malleshi, N.G.; Agarwal, A.; Tiwari, A.; Sood, S. Nutritional quality and health benefits. Millets and pseudo cereals. In Millets and Pseudo Cereals; Woodhead Publishing: Sawton, UK, 2021; pp. 159–168. [Google Scholar]
  62. Hu, H.; Zhao, Y.; Feng, Y.; Yang, X.; Li, Y.; Wu, Y.; Yuan, L.; Zhang, J.; Li, T.; Huang, H.; et al. Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2023, 117, 149–159. [Google Scholar] [CrossRef] [PubMed]
  63. Watling, C.Z.; Wojt, A.; Florio, A.A.; Butera, G.; Albanes, D.; Weinstein, S.J.; Huang, W.-Y.; Parisi, D.; Zhang, X.; Graubard, B.I.; et al. Fiber and whole grain intakes in relation to liver cancer risk: An analysis in two prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology 2024. [Google Scholar] [CrossRef] [PubMed]
  64. Saini, P.; Islam, M.; Das, R.; Shekhar, S.; Sinha, A.S.K.; Prasad, K. Wheat bran as potential source of dietary fiber: Prospects and challenges. J. Food Compos. Anal. 2023, 116, 105030. [Google Scholar] [CrossRef]
  65. Snauwaert, E.; Paglialonga, F.; Walle, J.V.; Wan, M.; Desloovere, A.; Polderman, N.; Renken-Terhaerdt, J.; Shaw, V.; Shroff, R. The benefits of dietary fiber: The gastrointestinal tract and beyond. Pediatr. Nephrol. 2023, 38, 2929–2938. [Google Scholar] [CrossRef] [PubMed]
  66. Khan, J.; Khan, M.Z.; Ma, Y.; Meng, Y.; Mushtaq, A.; Shen, Q.; Xue, Y. Overview of the composition of whole grains’ phenolic acids and dietary fibre and their effect on chronic non-communicable diseases. Int. J. Environ. Res. Public Health 2022, 19, 3042. [Google Scholar] [CrossRef] [PubMed]
  67. Waddell, I.S.; Orfila, C. Dietary fiber in the prevention of obesity and obesity-related chronic diseases: From epidemiological evidence to potential molecular mechanisms. Crit. Rev. Food Sci. Nutr. 2023, 63, 8752–8767. [Google Scholar] [CrossRef] [PubMed]
  68. Chauhan, M.; Mahanty, J.; Kumar, S.; Singh, H.; Sharma, A. An Insight into the Functional Benefit of Phenolic Acids from Whole Grains: An Update. Cur. Nutr. Food Sci. 2023, 19, 906–921. [Google Scholar] [CrossRef]
  69. Wood, P.J. Cereal β-glucans in diet and health. J. Cereal Sci. 2007, 46, 230–238. [Google Scholar] [CrossRef]
  70. Mathews, R.; Shete, V.; Chu, Y. The effect of cereal Β-glucan on body weight and adiposity: A review of efficacy and mechanism of action. Crit. Rev. Food Sci. Nut. 2023, 63, 3838–3850. [Google Scholar] [CrossRef] [PubMed]
  71. Neyrinck, A.M.; Possemiers, S.; Druart, C.; Van de Wiele, T.; De Backer, F.; Cani, P.D.; Larondelle, Y.; Delzenne, N.M. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 2011, 6, e20944. [Google Scholar] [CrossRef] [PubMed]
  72. Rosicka-Kaczmarek, J.; Komisarczyk, A.; Nebesny, E.; Makowski, B. The influence of arabinoxylans on the quality of grain industry products. Eur. J. Food Res. Nutr. 2016, 242, 295–303. [Google Scholar] [CrossRef]
  73. Kellow, N.J.; Walker, K.Z. Authorised EU health claim for arabinoxylan. In Foods, Nutrients and Food Ingredients with Authorised EU Health Claims; Woodhead Publishing: Sawton, UK, 2018; pp. 201–218. [Google Scholar]
  74. Chen, Z.; Li, S.; Fu, Y.; Li, C.; Chen, D.; Chen, H. Arabinoxylan structural characteristics, interaction with gut microbiota and potential health functions. J. Funct. Food 2019, 54, 536–551. [Google Scholar] [CrossRef]
  75. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to arabinoxylan produced from wheat endosperm and reduction of post-prandial glycaemic responses (ID 830) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J. 2011, 9, 2205. [Google Scholar] [CrossRef]
  76. Zhong, Y.; Marungruang, N.; Fåk, F.; Nyman, M. Effects of two whole-grain barley varieties on caecal SCFA, gut microbiota and plasma inflammatory markers in rats consuming low-and high-fat diets. Br. J. Nutr. 2015, 113, 1558–1570. [Google Scholar] [CrossRef] [PubMed]
  77. Liu, B.; Lin, Q.; Yang, T.; Zeng, L.; Shi, L.; Chen, Y.; Luo, F. Oat β-glucan ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. Food Funct. 2015, 6, 3454–3463. [Google Scholar] [CrossRef] [PubMed]
  78. Keegstra, K.; Walton, J. β-Glucans—brewer’s bane, dietician’s delight. Science 2006, 311, 1872–1873. [Google Scholar] [CrossRef] [PubMed]
  79. Slavin, J.L.; Tucker, M.; Harriman, C.; Jonnalagadda, S.S. Whole grains: Definition, dietary recommendations, and health benefits. Cereal Foods World 2013, 58, 191–198. [Google Scholar] [CrossRef]
  80. Hu, J.; Wang, J.; Li, Y.; Xue, K.; Kan, J. Use of Dietary Fibers in Reducing the Risk of Several Cancer Types: An Umbrella Review. Nutrients 2023, 15, 2545. [Google Scholar] [CrossRef] [PubMed]
  81. Mao, L.; Kitani, A.; Strober, W.; Fuss, I.J. The role of NLRP3 and IL-1β in the pathogenesis of inflammatory bowel disease. Front. Immunol. 2018, 9, 2566. [Google Scholar] [CrossRef]
  82. Zhang, H.; Gong, C.; Qu, L.; Ding, X.; Cao, W.; Chen, H.; Zhang, B.; Zhou, G. Therapeutic effects of triptolide via the inhibition of IL-1β expression in a mouse model of ulcerative colitis. Exp. Ther. Med. 2016, 12, 1279–1286. [Google Scholar] [CrossRef] [PubMed]
  83. Shmuel-Galia, L.; Aychek, T.; Fink, A.; Porat, Z.; Zarmi, B.; Bernshtein, B.; Brenner, O.; Jung, S.; Shai, Y. Neutralization of pro-inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis. EMBO J. 2016, 35, 685–698. [Google Scholar] [CrossRef] [PubMed]
  84. Zagoskina, N.V.; Zubova, M.Y.; Nechaeva, T.L.; Kazantseva, V.V.; Goncharuk, E.A.; Katanskaya, V.M.; Baranova, E.N.; Aksenova, M.A. Polyphenols in plants: Structure, biosynthesis, abiotic stress regulation, and practical applications. Int. J. Mol. Sci. 2023, 24, 13874. [Google Scholar] [CrossRef] [PubMed]
  85. Sahu, R.; Mandal, S.; Das, P.; Ashraf, G.J.; Dua, T.K.; Paul, P.; Nandi, G.; Khanra, R. The bioavailability, health advantages, extraction method, and distribution of free and bound phenolics of rice, wheat, and maize: A review. Food Chem. Adv. 2023, 3, 100484. [Google Scholar] [CrossRef]
  86. Perez-Jimenez, J.; Neveu, V.; Vos, F.; Scalbert, A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: An application of the phenol-explorer database. J. Agri. Food Chem. 2010, 58, 4959–4969. [Google Scholar] [CrossRef] [PubMed]
  87. Ragaee, S.; Seetharaman, K.; Abdel-Aal, E.S.M. The impact of milling and thermal processing on phenolic compounds in cereal grains. Crit. Rev. Food. Sci. Nutr. 2014, 54, 837–849. [Google Scholar] [CrossRef] [PubMed]
  88. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [Google Scholar] [CrossRef] [PubMed]
  89. Obayiuwana, O.A. Phenolic Acid Content and Fibre in Nigerian Wholegrains; Their Metabolism, and Potential Cardiovascular Benefits. Doctoral Dissertation, University of Roehampton, London, UK, 2023. [Google Scholar]
  90. Liu, R.H. Health Benefits of Dietary Phytochemicals in Whole Foods. In Nutritional Health: Strategies for Disease Prevention; Humana: Cham, Switzerland, 2023; pp. 177–190. [Google Scholar]
  91. Irakli, M.N.; Samanidou, V.F.; Biliaderis, C.G.; Papadoyannis, I.N. Development and validation of an HPLC-method for determination of free and bound phenolic acids in cereals after solid-phase extraction. Food Chem. 2012, 134, 1624–1632. [Google Scholar] [CrossRef] [PubMed]
  92. Hassan, S.M. Nutritional, Functional and Bioactive Properties of Sorghum (Sorghum Bicolor I. Moench) with its Future Outlooks: A Review. Open J. Nutr. Food Sci. 2023, 5, 1030. [Google Scholar]
  93. Chandrasekara, A.; Shahidi, F. Determination of antioxidant activity in free and hydrolyzed fractions of millet grains and characterization of their phenolic profiles by HPLC-DAD-ESI-MSn. J. Func. Food 2011, 3, 144–158. [Google Scholar] [CrossRef]
  94. Žilić, S.; Serpen, A.; Akıllıoğlu, G.; Gökmen, V.; Vančetović, J. Phenolic compounds, carotenoids, anthocyanins, and antioxidant capacity of colored maize (Zea mays L.) kernels. J. Agric. Food Chem. 2012, 60, 1224–1231. [Google Scholar] [CrossRef] [PubMed]
  95. Hithamani, G.; Srinivasan, K. Bioaccessibility of polyphenols from wheat (Triticum aestivum), sorghum (Sorghum bicolor), green gram (Vigna radiata), and chickpea (Cicer arietinum) as influenced by domestic food processing. J. Agric. Food Chem. 2014, 62, 11170–11179. [Google Scholar] [CrossRef]
  96. N’Dri, D.; Mazzeo, T.; Zaupa, M.; Ferracane, R.; Fogliano, V.; Pellegrini, N. Effect of cooking on the total antioxidant capacity and phenolic profile of some whole-meal African cereals. J. Sci. Food Agri. 2013, 93, 29–36. [Google Scholar] [CrossRef] [PubMed]
  97. Viswanath, V.; Urooj, A.; Malleshi, N.G. Evaluation of antioxidant and antimicrobial properties of finger millet polyphenols (Eleusine coracana). Food Chem. 2009, 114, 340–346. [Google Scholar] [CrossRef]
  98. Chandrasekara, A.; Shahidi, F. Bioactivities and antiradical properties of millet grains and hulls. J. Agric. Food Chem. 2011, 59, 9563–9571. [Google Scholar] [CrossRef] [PubMed]
  99. Gómez-Caravaca, A.M.; Iafelice, G.; Verardo, V.; Marconi, E.; Caboni, M.F. Influence of pearling process on phenolic and saponin content in quinoa (Chenopodium quinoa Willd). Food Chem. 2014, 157, 174–178. [Google Scholar] [CrossRef] [PubMed]
  100. Repo-Carrasco-Valencia, R.; Hellström, J.K.; Pihlava, J.M.; Mattila, P.H. Flavonoids and other phenolic compounds in Andean indigenous grains: Quinoa (Chenopodium quinoa), kañiwa (Chenopodium pallidicaule) and kiwicha (Amaranthus caudatus). Food Chem. 2010, 120, 128–133. [Google Scholar] [CrossRef]
  101. Kandil, A.; Li, J.; Vasanthan, T.; Bressler, D.C. Phenolic acids in some cereal grains and their inhibitory effect on starch liquefaction and saccharification. J. Agri. Food Chem. 2012, 60, 8444–8449. [Google Scholar] [CrossRef] [PubMed]
  102. Van Hung, P. Phenolic compounds of cereals and their antioxidant capacity. Crit. Rev. Food Sci. Nutr. 2016, 56, 25–35. [Google Scholar] [CrossRef] [PubMed]
  103. Shao, Y.; Bao, J. Polyphenols in whole rice grain: Genetic diversity and health benefits. Food Chem. 2015, 180, 86–97. [Google Scholar] [CrossRef] [PubMed]
  104. Sène, M.; Gallet, C.; Doré, T. Phenolic compounds in a Sahelian sorghum (Sorghum bicolor) genotype (CE145–66) and associated soils. J. Chem. Ecol. 2001, 27, 81–92. [Google Scholar] [CrossRef] [PubMed]
  105. Gade, A.; Kumar, M.S. Gut microbial metabolites of dietary polyphenols and their potential role in human health and diseases. J. Physiol. Biochem. 2023, 79, 695–718. [Google Scholar] [CrossRef] [PubMed]
  106. Bié, J.; Sepodes, B.; Fernandes, P.C.; Ribeiro, M.H. Polyphenols in health and disease: Gut microbiota, bioaccessibility, and bioavailability. Compounds 2023, 3, 40–72. [Google Scholar] [CrossRef]
  107. Anantharaju, P.G.; Gowda, P.C.; Vimalambike, M.G.; Madhunapantula, S.V. An overview on the role of dietary phenolics for the treatment of cancers. Nutr. J. 2016, 15, 99. [Google Scholar] [CrossRef] [PubMed]
  108. Grande, T.; Souid, A.; Ciardi, M.; Della Croce, C.M.; Frassinetti, S.; Bramanti, E.; Longo, V.; Pozzo, L. Evaluation of antioxidant and antimicrobial activities of whole flours obtained from different species of Triticum genus. Eur. Food Res. Technol. 2023, 249, 1575–1587. [Google Scholar] [CrossRef]
  109. Abdel-Wahab, M.H.; El-Mahdy, M.A.; Abd-Ellah, M.F.; Helal, G.K.; Khalifa, F.; Hamada, F.M.A. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat’s heart. Pharmacol. Res. 2003, 48, 461–465. [Google Scholar] [CrossRef] [PubMed]
  110. Janicke, B.; Hegardt, C.; Krogh, M.; Önning, G.; Åkesson, B.; Cirenajwis, H.M.; Oredsson, S.M. The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells. Nutr. Cancer 2011, 63, 611–622. [Google Scholar] [CrossRef] [PubMed]
  111. Chao, C.Y.; Mong, M.C.; Chan, K.C.; Yin, M.C. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol. Nut. Food Res. 2010, 54, 388–395. [Google Scholar] [CrossRef]
  112. Fahrioğlu, U.; Dodurga, Y.; Elmas, L.; Seçme, M. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro. Gene 2016, 576, 476–482. [Google Scholar] [CrossRef] [PubMed]
  113. Hou, Y.Z.; Zhao, G.R.; Yang, J.; Yuan, Y.J.; Zhu, G.G.; Hiltunen, R. Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sci. 2004, 75, 1775–1786. [Google Scholar] [CrossRef]
  114. Narasimhan, A.; Chinnaiyan, M.; Karundevi, B. Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat. Eur. J. Pharmacol. 2015, 761, 391–397. [Google Scholar] [CrossRef] [PubMed]
  115. Eitsuka, T.; Tatewaki, N.; Nishida, H.; Kurata, T.; Nakagawa, K.; Miyazawa, T. Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid. Biochem. Biophys. Res. Commun. 2014, 453, 606–611. [Google Scholar] [CrossRef] [PubMed]
  116. Ji, L.; Deng, H.; Xue, H.; Wang, J.; Hong, K.; Gao, Y.; Kang, X.; Fan, G.; Huang, W.; Zhan, J.; et al. Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota. Compr. Rev. Food Sci. Food Saf. 2023, 22, 1128–1147. [Google Scholar] [CrossRef] [PubMed]
  117. Roney, M.; Dubey, A.; Zamri, N.B.; Aluwi, M.F.F.M. Inhibitory effect of Sinapic acid derivatives targeting structural and non-structural proteins of dengue virus serotype 2: An in-silico assessment. Mol. Aspects Med. 2023, 2, 100028. [Google Scholar] [CrossRef]
  118. DMoreno, D.A.; Pérez-Balibrea, S.; Ferreres, F.; Gil-Izquierdo, Á.; García-Viguera, C. Acylated anthocyanins in broccoli sprouts. Food Chem. 2010, 123, 358–363. [Google Scholar] [CrossRef]
  119. Maddox, C.E.; Laur, L.M.; Tian, L. Antibacterial activity of phenolic compounds against the phytopathogen Xylella fastidiosa. Curr. Microbiol. 2010, 60, 53–58. [Google Scholar] [CrossRef] [PubMed]
  120. Tuncer, S.Ç.; Akarsu, S.A.; Küçükler, S.; Gür, C.; Kandemir, F.M. Effects of sinapic acid on lead acetate-induced oxidative stress, apoptosis and inflammation in testicular tissue. Environ. Toxicol. 2023, 38, 2656–2667. [Google Scholar] [CrossRef]
  121. Yun, K.-J.; Koh, D.-J.; Kim, S.-H.; Park, S.J.; Ryu, J.H.; Kim, D.-G.; Lee, J.-Y.; Lee, K.-T. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-κB inactivation. J. Agric. Food Chem. 2008, 56, 10265–10272. [Google Scholar] [CrossRef]
  122. Taştemur, Ş.; Hacısüleyman, L.; Karataş, Ö.; Yulak, F.; Ataseven, H. Anticancer activity of sinapic acid by inducing apoptosis in HT-29 human colon cancer cell line. Can. J. Physiol. Pharmacol. 2023, 101, 361–368. [Google Scholar] [CrossRef] [PubMed]
  123. Kanchana, G.; Shyni, W.J.; Rajadurai, M.; Periasamy, R. Evaluation of antihyperglycemic effect of sinapic acid in normal and streptozotocin-induced diabetes in albino rats. World J. Pharmacol. 2011, 5, 33–39. [Google Scholar]
  124. Sun, X.; Ito, H.; Masuoka, T.; Kamei, C.; Hatano, T. Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biol. Pharm. Bull. Biological 2008, 30, 1727–1731. [Google Scholar] [CrossRef] [PubMed]
  125. Yoon, B.H.; Jung, J.W.; Lee, J.-J.; Cho, Y.-W.; Jang, C.-G.; Jin, C.; Oh, T.H.; Ryu, J.H. Anxiolytic-Like effe1cts of sinapic acid in mice. Pharm. Sci. 2008, 35, 67. [Google Scholar]
  126. He, L.; Li, H.T.; Guo, S.W.; Liu, L.F.; Qiu, J.B.; Li, F.; Cai, B.C. Inhibitory effects of sinapine on activity of acetylcholinesterase in cerebral homogenate and blood serum of rats. China J. Chin. Mater. Medica 2008, 24, 813–815. [Google Scholar]
  127. Ferreres, F.; Fernandes, F.; Sousa, C.; Valentao, P.; Pereira, J.A.; Andrade, P.B. Metabolic and bioactivity insights into Brassica oleracea var. acephala. J. Agric. Food Chem. 2009, 57, 8884–8892. [Google Scholar] [CrossRef] [PubMed]
  128. Wakamatsu, D.; Morimura, S.; Sawa, T.; Kida, K.; Nakai, C.; Maeda, H. Isolation, identification, and structure of a potent alkyl-peroxyl radical scavenger in crude canola oil, canolol. Biosci. Biotechnol. Biochem. 2005, 69, 1568–1574. [Google Scholar] [CrossRef] [PubMed]
  129. Kuwahara, H.; Kanazawa, A.; Wakamatu, D.; Morimura, S.; Kida, K.; Akaike, T.; Maeda, H. Antioxidative and antimutagenic activities of 4-vinyl-2, 6-dimethoxyphenol (canolol) isolated from canola oil. J. Agric. Food Chem. 2004, 52, 4380–4387. [Google Scholar] [CrossRef] [PubMed]
  130. Park, J.; Lee, B.; Choi, H.; Kim, W.; Kim, H.J.; Cheong, H. Antithrombosis activity of protocatechuic and shikimic acids from functional plant Pinus densiflora Sieb. et Zucc needles. J. Nat. Med. 2016, 70, 492–501. [Google Scholar] [CrossRef] [PubMed]
  131. Choi, J.H.; Kim, S. In vitro antithrombotic, hematological toxicity, and inhibitor studies of protocatechuic, isovanillic, and p-hydroxybenzoic acids from Maclura tricuspidata (Carr.) Bur. Molecules 2022, 27, 3496. [Google Scholar] [CrossRef] [PubMed]
  132. Yeh, R.D.; Chen, J.C.; Lai, T.Y.; Yang, J.S.; Yu, C.S.; Chiang, J.H.; Lu, C.C.; Yang, S.T.; Yu, C.C.; Chang, S.J.; et al. Gallic acid induces G0/G1 phase arrest and apoptosis in human leukemia HL-60 cells through inhibiting cyclin D and E, and activating mitochondria-dependent pathway. Anticancer Res. 2011, 31, 2821–2832. [Google Scholar] [PubMed]
  133. Veluri, R.; Singh, R.P.; Liu, Z.; Thompson, J.A.; Agarwal, R.; Agarwal, C. Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis 2006, 27, 1445–1453. [Google Scholar] [CrossRef]
  134. Kamatham, S.; Kumar, N.; Gudipalli, P. Isolation and characterization of gallic acid and methyl gallate from the seed coats of Givotia rottleriformis Griff. and their anti-proliferative effect on human epidermoid carcinoma A431 cells. Toxicol. Rep. 2015, 2, 520–529. [Google Scholar] [CrossRef] [PubMed]
  135. Kumar, R.; Khurana, N.; Kaur, B. Effect of INM 176 on ischemia reperfusion injury using rat heart model. Asian J. Pharm. Clin. Res. 2017, 10, 106–109. [Google Scholar] [CrossRef]
  136. Kumar, R.; Kumar, R.; Anand, A.; Mahajan, R.; Khatik, G.L.; Duggal, N.; Mehta, M.; Satija, S.; Sharma, N.; Khurana, N. Potential of Prediction of Activity Spectra of Substances Software to Justify 3Rs Ethics for In Vivo Anti-Alzheimer’s Studies of Phytochemicals. Int. J. Green. Pharm. 2018, 12, 66–72. [Google Scholar]
  137. Sharma, N.; Tiwari, N.; Vyas, M.; Khurana, N.; Muthuraman, A.; Utreja, P. An overview of therapeutic effects of vanillic acid. Plant Arch. 2020, 20, 3053–3059. [Google Scholar]
  138. Srinivasulu, C.; Ramgopal, M.; Ramanjaneyulu, G.; Anuradha, C.M.; Kumar, C.S. Syringic acid (SA)—A review of its occurrence, biosynthesis, pharmacological and industrial importance. Biomed. Pharmacother. 2018, 108, 547–557. [Google Scholar] [CrossRef] [PubMed]
  139. Della Pepa, G.; Vetrani, C.; Vitale, M.; Riccardi, G. Wholegrain intake and risk of type 2 diabetes: Evidence from epidemiological and intervention studies. Nutrients 2018, 10, 1288. [Google Scholar] [CrossRef] [PubMed]
  140. Sang, S.; Chu, Y. Whole grain oats, more than just a fiber: Role of unique phytochemicals. Mol. Nutr. Food Res. 2017, 61, 1600715. [Google Scholar] [CrossRef] [PubMed]
  141. Sang, S.; Landberg, R. The chemistry behind health effects of whole grains. Mol. Nutr. Food Res. 2017, 61, 1770074. [Google Scholar] [CrossRef] [PubMed]
  142. Xu, Y.; Wan, Q.; Feng, J.; Du, L.; Li, K.; Zhou, Y. Whole grain diet reduces systemic inflammation: A meta-analysis of 9 randomized trials. Medicine 2018, 97, e12995. [Google Scholar] [CrossRef] [PubMed]
  143. Hajihashemi, P.; Haghighatdoost, F. Effects of whole-grain consumption on selected biomarkers of systematic inflammation: A systematic review and meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 2019, 38, 275–285. [Google Scholar] [CrossRef] [PubMed]
  144. Zamaratskaia, G.; Omar, N.A.M.; Brunius, C.; Hallmans, G.; Johansson, J.-E.; Andersson, S.-O.; Larsson, A.; Åman, P.; Landberg, R. Consumption of whole grain/bran rye instead of refined wheat decrease concentrations of TNF-R2, e-selectin, and endostatin in an exploratory study in men with prostate cancer. Clin. Nutr. 2020, 39, 159–165. [Google Scholar] [CrossRef] [PubMed]
  145. Brownlee, I.A.; Moore, C.; Chatfield, M.; Richardson, D.P.; Ashby, P.; Kuznesof, S.A.; Jebb, S.A.; Seal, C.J. Markers of cardiovascular risk are not changed by increased whole-grain intake: The WHOLEheart study, a randomised, controlled dietary intervention. Br. J. Nutr. 2010, 104, 125–134. [Google Scholar] [CrossRef] [PubMed]
  146. Kwok, C.S.; Gulati, M.; Michos, E.D.; Potts, J.; Wu, P.; Watson, L.; Loke, Y.K.; Mallen, C.; Mamas, M.A. Dietary components and risk of cardiovascular disease and all-cause mortality: A review of evidence from meta-analyses. Eur. J. Prev. Cardiol. 2019, 26, 1415–1429. [Google Scholar] [CrossRef] [PubMed]
  147. Neuenschwander, M.; Ballon, A.; Weber, K.S.; Norat, T.; Aune, D.; Schwingshackl, L.; Schlesinger, S. Role of diet in type 2 diabetes incidence: Umbrella review of meta-analyses of prospective observational studies. BMJ 2019, 366, 12368. [Google Scholar] [CrossRef]
  148. Tieri, M.; Ghelfi, F.; Vitale, M.; Vetrani, C.; Marventano, S.; Lafranconi, A.; Godos, J.; Titta, L.; Gambera, A.; Alonzo, E.; et al. Whole grain consumption and human health: An umbrella review of observational studies. Int. J. Food Sci. Nutr. 2020, 71, 668–677. [Google Scholar] [CrossRef]
  149. Ampatzoglou, A.; Atwal, K.K.; Maidens, C.M.; Williams, C.L.; Ross, A.B.; Thielecke, F.; Jonnalagadda, S.S.; Kennedy, O.B.; Yaqoob, P. Increased whole grain consumption does not affect blood biochemistry, body composition, or gut microbiology in healthy, low-habitual whole grain consumers. J. Nutr. 2015, 145, 215–221. [Google Scholar] [CrossRef] [PubMed]
  150. Andersen, J.L.M.; Halkjær, J.; Rostgaard-Hansen, A.L.; Martinussen, N.; Lund, A.-S.Q.; Kyrø, C.; Tjønneland, A.; Olsen, A. Intake of whole grain and associations with lifestyle and demographics: A cross-sectional study based on the Danish Diet, Cancer and Health—Next Generations cohort. Eur. J. Nutr. 2021, 60, 883–895. [Google Scholar] [CrossRef] [PubMed]
  151. Egeberg, R.; Frederiksen, K.; Olsen, A.; Johnsen, N.F.; Loft, S.; Overvad, K.; Tjønneland, A. Intake of wholegrain products is associated with dietary, lifestyle, anthropometric and socio-economic factors in Denmark. Public Health Nutr. 2009, 12, 1519–1530. [Google Scholar] [CrossRef] [PubMed]
  152. Mazidi, M.; Kengne, A.P.; Mikhailidis, D.P.; Cicero, A.F.; Banach, M. Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in US adults. Ann. Med. 2018, 50, 1–6. [Google Scholar] [CrossRef]
  153. Qi, L.; Van Dam, R.M.; Liu, S.; Franz, M.; Mantzoros, C.; Hu, F.B. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 2006, 29, 207–211. [Google Scholar] [CrossRef] [PubMed]
  154. Wilczak, J.; Błaszczyk, K.; Kamola, D.; Gajewska, M.; Harasym, J.P.; Jałosińska, M.; Gudej, S.; Suchecka, D.; Oczkowski, M.; Gromadzka-Ostrowska, J. The effect of low or high molecular weight oat beta-glucans on the inflammatory and oxidative stress status in the colon of rats with LPS-induced enteritis. Food Funct. 2015, 6, 590–603. [Google Scholar] [CrossRef] [PubMed]
  155. Shahidi, F.; Peng, H. Bioaccessibility and bioavailability of phenolic compounds. J. Food Bioact. 2018, 4, 11–68. [Google Scholar] [CrossRef]
  156. Esmaillzadeh, A.; Kimiagar, M.; Mehrabi, Y.; Azadbakht, L.; Hu, F.B.; Willett, W.C. Dietary patterns and markers of systemic inflammation among Iranian women. J. Nutr. 2007, 137, 992–998. [Google Scholar] [CrossRef]
  157. McRorie, J.W., Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: What to look for and how to recommend an effective fiber therapy. Nutr. Today 2015, 50, 82. [Google Scholar] [CrossRef] [PubMed]
  158. Jacobs, D.R., Jr. The whole cereal grain is more informative than cereal fibre. Nat. Rev. Endocrinol. 2015, 11, 389–390. [Google Scholar] [CrossRef]
  159. Pragasam, S.J.; Venkatesan, V.; Rasool, M. Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation 2013, 36, 169–176. [Google Scholar] [CrossRef] [PubMed]
  160. Ibitoye, O.B.; Ajiboye, T.O. Dietary phenolic acids reverse insulin resistance, hyperglycaemia, dyslipidaemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome rats. Arch. Physiol. Biochem. 2018, 124, 410–417. [Google Scholar] [CrossRef] [PubMed]
  161. Koenig, R.; Dickman, J.R.; Kang, C.; Zhang, T.; Chu, Y.F.; Ji, L.L. Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women. Nutr. J. 2014, 13, 21. [Google Scholar] [CrossRef] [PubMed]
  162. Liu, L.; Zubik, L.; Collins, F.W.; Marko, M.; Meydani, M. The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 2004, 175, 39–49. [Google Scholar] [CrossRef] [PubMed]
  163. Sur, R.; Nigam Sur, A.; Grote, D.; Liebel, F.; Southall, M.D. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch. Dermatol. 2008, 300, 569–574. [Google Scholar] [CrossRef] [PubMed]
  164. Anson, N.M.; Aura, A.-M.; Selinheimo, E.; Mattila, I.; Poutanen, K.; Berg, R.v.D.; Havenaar, R.; Bast, A.; Haenen, G.R.M.M. Bioprocessing of wheat bran in whole wheat bread increases the bioavailability of phenolic acids in men and exerts antiinflammatory effects ex vivo. J. Nutr. 2011, 141, 137–143. [Google Scholar] [CrossRef] [PubMed]
  165. Tetens, I. Substituting whole grain for refined grain: What is needed to strengthen the scientific evidence for health outcomes? Am. J. Clin. 2017, 105, 545–546. [Google Scholar] [CrossRef] [PubMed]
  166. Vinolo, M.A.; Rodrigues, H.G.; Nachbar, R.T.; Curi, R. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3, 858–876. [Google Scholar] [CrossRef] [PubMed]
  167. Fischer, N.; Sechet, E.; Friedman, R.; Amiot, A.; Sobhani, I.; Nigro, G.; Sansonetti, P.J.; Sperandio, B. Deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge. Proc. Natl. Acad. Sci. USA 2016, 113, 2993–3001. [Google Scholar] [CrossRef] [PubMed]
  168. Felice, C.; Lewis, A.; Armuzzi, A.; Lindsay, J.O.; Silver, A. Selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Aliment. Pharmacol. Ther. 2015, 41, 26–38. [Google Scholar] [CrossRef] [PubMed]
  169. Lee, J.C.-Y.; AlGhawas, D.S.; Poutanen, K.; Leung, K.S.; Oger, C.; Galano, J.-M.; Durand, T.; El-Nezami, H. Dietary oat bran increases some proinflammatory polyunsaturated fatty-acid oxidation products and reduces anti-inflammatory products in apolipoprotein E−/− mice. Lipids 2018, 53, 785–796. [Google Scholar] [CrossRef]
  170. Martínez, I.; Lattimer, J.M.; Hubach, K.L.; Case, J.A.; Yang, J.; Weber, C.G.; Louk, J.A.; Rose, D.J.; Kyureghian, G.; Peterson, D.A.; et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013, 7, 269–280. [Google Scholar] [CrossRef] [PubMed]
Table 1. Targeted cereals used for the study.
Table 1. Targeted cereals used for the study.
CerealBotanical Name
RyeSecalecereale L.
CornZea mays L.
SorghumSorghum bicolor
MilletsEleusine coracana (L.) Gaertn.
TriticaleTriticosecale Wittmack
Pseudo-CerealBotanical Name
QuinoaChenopodium quinoa Willd.
Table 3. Dietary fiber in whole grains and their health potential.
Table 3. Dietary fiber in whole grains and their health potential.
GrainDietary FiberHealth PotentialReferences
Whole grainsArabinoxylansEnhance fecal biomass, improve gut health, lower LDL levels, lipid metabolism[71,72,73,74,75]
Whole grainsβ-glucanAnti-inflammation, decrease glycemic index, prebiotic effect, decrease blood lipids, modulate blood cholesterol and glucose levels, immune function[69,70,76,77,78,79]
Whole grainsTotal dietary fiberAnti-inflammation, anti-cardiovascular disease, antidiabetic, certain anticancer effects, body weight regulation[67,80,81,82,83]
Table 4. Chemical structures of targeted hydroxycinnamic acids and hydroxybenzoic acids.
Table 4. Chemical structures of targeted hydroxycinnamic acids and hydroxybenzoic acids.
Hydroxycinnamic AcidsNutrients 16 01047 i001
R1R2R3Chemical Structure
p-Coumaric acidHOHHNutrients 16 01047 i002
Ferulic acidHOHOCH3Nutrients 16 01047 i003
Caffeic acidOHOHOHNutrients 16 01047 i004
Sinapic acidOCH3OHOCH3Nutrients 16 01047 i005
Hydroxybenzoic AcidsNutrients 16 01047 i006
R1R2R3
p-Hydroxybenzoic acidHOHHNutrients 16 01047 i007
Gallic acidOHOHOHNutrients 16 01047 i008
Vanillic acidHOHOCH3Nutrients 16 01047 i009
Syringic acidOCH3OHOCH3Nutrients 16 01047 i010
Table 5. Review of hydroxycinnamic acids and hydroxybenzoic acids in targeted cereals, µg/g of dry weight.
Table 5. Review of hydroxycinnamic acids and hydroxybenzoic acids in targeted cereals, µg/g of dry weight.
Hydroxycinnamic Acids
Whole GrainFerulic Acidp-Coumaric AcidCaffeic AcidSinapic AcidReferences
Rye (Secalecereale L.)827.2 (218.7–1170.0)49.0 (29.9–70.0)16.2 (12.3–20.0)94.2 (51.7–140.0)[91,102]
Corn (Zea mays L.)94.2 (51.7–140.0)340.5 (97.0–584.0)15.0 (5.7–24.4)66.1 (52.9–79.3)[89,91,94,100,101]
Sorghum (Sorghum bicolor)66.1 (52.9–79.3)43.6 (3.8–83.4)32.1 (1.9–62.4)8.2[95]
Millet (Eleusine coracana (L.) Gaertn.)233.4 (20.0–571.3)46.0 (18.0–118.3)4.6 (1.1–8.2)46.7 (21.3–72.1)[96,97,98]
Triticale (Triticosecale Wittmack)46.7 (21.3–72.1)139.8 (21.2–258.5)9.9 (6.0–13.9)83.0 (50.0–140.0)[91,101]
Quinoa (Chenopodium quinoa Willd.)87.7 (23.7–150.0)48.6 (17.1–80.0)7.0-[99,100]
Hydroxybenzoic Acids
p-Hydroxybenzoic AcidGallic AcidVanillic AcidSyringic Acid
Rye (Secalecereale L.)14.1 (8.1–20.0)7.718.0 (15.9–20.0)6.3[91]
Corn (Zea mays L.)8.2 (4.9–11.6)55.4 (0.5–116.5)10.3 (5.4–15.4)45.3 (4.3–108.4)[91,101]
Sorghum (Sorghum bicolor)36.2 (6.1–148.0)28.0 (13.2–46.0)23.2 (8.3–50.7)16.9 (15.6–19.7)[94,104]
Millet (Eleusine coracana (L.) Gaertn.)3.068.6 (38.7–109.0)22.2 (11.0–33.3)13.1 (2.1–24.0)[89,96,97]
Triticale (Triticosecale Wittmack)7.1 (6.9–7.4)333.7 (123.4–544.0)446.0 (154.0–738.0)173.2 (5.3–341.0)[91,101]
Quinoa (Chenopodium quinoa Willd.)21.7 (13.8–29.0)-30.4 (11.7–110.0)-[100]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Khan, J.; Gul, P.; Rashid, M.T.; Li, Q.; Liu, K. Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation. Nutrients 2024, 16, 1047. https://doi.org/10.3390/nu16071047

AMA Style

Khan J, Gul P, Rashid MT, Li Q, Liu K. Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation. Nutrients. 2024; 16(7):1047. https://doi.org/10.3390/nu16071047

Chicago/Turabian Style

Khan, Jabir, Palwasha Gul, Muhammad Tayyab Rashid, Qingyun Li, and Kunlun Liu. 2024. "Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation" Nutrients 16, no. 7: 1047. https://doi.org/10.3390/nu16071047

APA Style

Khan, J., Gul, P., Rashid, M. T., Li, Q., & Liu, K. (2024). Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation. Nutrients, 16(7), 1047. https://doi.org/10.3390/nu16071047

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop